Is it sufficient to evaluate COVID‐19 infected critically ill patients only in terms of VTE risk factors? What about disease severity?

Is it sufficient to evaluate COVID‐19 infected critically ill patients only in terms of VTE risk factors? What about disease severity?

Bibliographic Details
Main Authors:	Fatma Yildirim, Mehmet Yildirim
Format:	Article
Language:	English
Published:	Wiley 2022-07-01
Series:	The Clinical Respiratory Journal
Online Access:	https://doi.org/10.1111/crj.13520

Similar Items

Antithrombin III levels in critically ill surgical patients: do they correlate with VTE?
by: Galinos Barmparas, et al.
Published: (2023-12-01)

Extended anticoagulation for VTE: what evidence justifies it?
by: Anushka Walia, et al.
Published: (2023-08-01)

Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE
by: Wei Xiong, et al.
Published: (2023-01-01)

VTE epidemiology and challenges for VTE prevention at the population level
by: Sigrid K. Brækkan, et al.
Published: (2023-03-01)

What’s new in VTE risk and prevention in orthopedic surgery
by: Susan R. Kahn, et al.
Published: (2020-03-01)

VTE Registry: What Can Be Learned from RIETE?
by: Inna Tzoran, et al.
Published: (2014-10-01)

“What will happen in the future?” A personal VTE journey
by: Ellen O’Rourke, et al.
Published: (2020-12-01)

Are we preventing VTE in patients with an infective exacerbation of chronic obstructive pulmonary disease - low adherence to VTE prophylaxis guidelines
by: Anmol Khanna
Published: (2016-12-01)

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
by: Sake J. van der Wall, et al.
Published: (2018-11-01)

VTE risk assessment in pregnancy
by: Karl Ewins, et al.
Published: (2020-02-01)

It is a sufficient condition only, not a necessary and sufficient condition, for decomposing wavefront aberrations
by: Lin Psang
Published: (2022-01-01)

UPPER GASTROINTESTINAL BLEEDING:IS ONLY AN INJECTION OF EPINEPHRINE SUFFICIENT? SUCCES RATES BY FORREST CLASSIFICATION
by: Ahmet Surek, et al.
Published: (2020-12-01)

VTE in ICU: Lessons from COVID-19
by: Xu Chu, et al.
Published: (2022-10-01)

Comparison of Cumulative Corticosteroid Doses for Critically Ill Patients with COVID-19
by: Burçin HALAÇLI, et al.
Published: (2023-01-01)

Severe Candida infections in critically ill patients with COVID-19
by: Despoina Koulenti, et al.
Published: (2023-10-01)

Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study
by: Ohoud Aljuhani, et al.
Published: (2022-04-01)

Recommendations from the ICM-VTE: general
by: Parvizi, J, et al.
Published: (2022)

Recommendations from the ICM-VTE: trauma
by: Ahn, J, et al.
Published: (2022)

Nitrous oxide and VTE – no laughing matter
by: Lucy A. Norris, et al.
Published: (2024-09-01)

Care Pathway of Venous Thromboembolism (VTE)
by: Liselotte van Dijk, et al.
Published: (2024-07-01)

Metabolomic Profile in Venous Thromboembolism (VTE)
by: Beata Franczyk, et al.
Published: (2021-07-01)

Prevention of VTE in orthopedic surgery patients
by: Federico Spandonaro, et al.
Published: (2013-10-01)

Risk Assessment for Cancer-Associated VTE
by: Alok A. Khorana, MD
Published: (2021-09-01)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
by: Patrick M. Honore, et al.
Published: (2018-11-01)

Neuropsychological Outcome of Critically Ill Patients with Severe Infection
by: Maria Della Giovampaola, et al.
Published: (2022-02-01)

Foreword. What is sufficiency?
by: Mamphela Ramphele
Published: (2024-08-01)

Research Note: What Do We Know About the Emerging Markets?
by: Tevfik Murat Yildirim
Published: (2014-07-01)

Comparison of critically ill COVID-19 and influenza patients with acute respiratory failure
by: Mehmet Yildirim, et al.
Published: (2022-05-01)

Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry
by: Ioannis T. Farmakis, et al.
Published: (2022-10-01)

Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis
by: Alessandro Laganà, et al.
Published: (2024-04-01)

Analysis of Readmissions Due to VTE—Using Hospital Data to Improve VTE Prophylaxis Compliance: A Quality Improvement Project
by: Muzamil Hamid Hussain MBBS, et al.
Published: (2023-06-01)

What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?
by: Philippe Cauchie, et al.
Published: (2021-07-01)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
by: Bethany Samuelson Bannow, et al.
Published: (2021-07-01)

Predictors of adverse outcome of severe infections in critically ill children
by: K. V. Pshenisnov, et al.
Published: (2023-05-01)

Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID‐19
by: George Goshua, et al.
Published: (2021-01-01)

Comparative Analysis and Validation of the IMPEDED VTE, IMPEDE VTE, and SAVED Risk Models in Predicting Venous Thromboembolism in Multiple Myeloma Patients: A Retrospective Study in Türkiye
by: Vildan Gursoy, et al.
Published: (2025-03-01)

Risks and features of secondary infections in severe and critical ill COVID-19 patients
by: Haocheng Zhang, et al.
Published: (2020-01-01)

Necessary and Sufficient Conditions of Optimality for a Damped Hyperbolic Equation in One-Space Dimension
by: Ismail Kucuk, et al.
Published: (2014-01-01)

Learners’ views about cloud computing-based group activities
by: Yildirim Serkan, et al.
Published: (2017-01-01)

Reassessing the Risk of Venous Thromboembolism (VTE) Events in Women
by: Changhuai He MD, et al.
Published: (2024-12-01)